-
EP0649410
European procedure
Extract from the Register of European Patents
EP About this file: EP0649410
| EP0649410 - ANILIDE DERIVATIVES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.03.1998 Database last updated on 02.11.2024 | Most recent event Tooltip | 06.03.1998 | No opposition filed within time limit | published on 22.04.1998 [1998/17] | Applicant(s) | For all designated states LABORATOIRES GLAXO SA 43 rue Vineuse 75116 Paris / FR | [N/P] |
| Former [1995/17] | For all designated states LABORATOIRES GLAXO SA 43 rue Vineuse F-75016 Paris / FR | Inventor(s) | 01 /
DUMAITRE, Bernard André, Laboratoires Glaxo S.A. Ctr de Rech, Z.A. de Courtaboeuf, 25 av. de Québec F-91940 Les Ulis / FR | 02 /
DODIC, Nerina, Lab. Glaxo S.A., Ctr de Rechereches Z.A. de Courtaboeuf, 25, avenue de Québec F-91940 Les Ulis / FR | 03 /
DAUGAN, Alain Claude-Marie, Laboratoires Glaxo SA Ctr. de Rech., ZA de Courtaboeuf, 25 av. de Québec F-91940 Les Ulis / FR | 04 /
PIANETTI, Pascal Maurice Charles, Lab. Glaxo S.A. Ctr. de Rech., ZA de Courtaboeuf, 25 av. de Québec F-91940 Les Ulis / FR | [1995/17] | Representative(s) | Filler, Wendy Anne, et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [1995/17] | Filler, Wendy Anne, et al Glaxo Wellcome plc Glaxo House Berkeley Avenue Greenford, Middlesex UB6 0NN / GB | Application number, filing date | 93915865.5 | 08.07.1993 | [1995/17] | WO1993EP01802 | Priority number, date | GB19920014667 | 10.07.1992 Original published format: GB 9214667 | GB19920014668 | 10.07.1992 Original published format: GB 9214668 | GB19920014675 | 10.07.1992 Original published format: GB 9214675 | [1995/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9401408 | Date: | 20.01.1994 | Language: | EN | [1994/03] | Type: | A1 Application with search report | No.: | EP0649410 | Date: | 26.04.1995 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.01.1994 takes the place of the publication of the European patent application. | [1995/17] | Type: | B1 Patent specification | No.: | EP0649410 | Date: | 02.05.1997 | Language: | EN | [1997/18] | Search report(s) | International search report - published on: | EP | 20.01.1994 | Classification | IPC: | C07D217/04, A61K31/47, C07D401/12, C07D335/16, C07C235/84, C07C233/80, C07D215/48, C07D215/52, C07D311/86, C07D217/26, C07D241/46 | [1995/17] | CPC: |
C07D401/12 (EP,US);
A61P35/00 (EP);
C07C233/70 (EP,US);
C07C233/75 (EP,US);
C07D209/42 (EP,US);
C07D215/48 (EP,US);
C07D215/52 (EP,US);
C07D217/04 (EP,US);
C07D217/26 (EP,US);
C07D241/44 (EP,US);
C07D241/46 (EP,US);
C07D335/16 (EP,US);
C07D405/12 (EP,US);
C07D409/12 (EP,US);
C07D409/14 (EP,US);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1995/17] | Title | German: | ANILIDE-DERIVATE | [1995/17] | English: | ANILIDE DERIVATIVES | [1995/17] | French: | DERIVES D'ANILIDE | [1995/17] | Entry into regional phase | 08.12.1994 | National basic fee paid | 08.12.1994 | Designation fee(s) paid | 08.12.1994 | Examination fee paid | Examination procedure | 28.01.1994 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 08.12.1994 | Examination requested [1995/17] | 21.02.1996 | Despatch of a communication from the examining division (Time limit: M04) | 27.06.1996 | Reply to a communication from the examining division | 12.08.1996 | Despatch of communication of intention to grant (Approval: Yes) | 29.10.1996 | Communication of intention to grant the patent | 27.01.1997 | Fee for grant paid | 27.01.1997 | Fee for publishing/printing paid | Opposition(s) | 03.02.1998 | No opposition filed within time limit [1998/17] | Fees paid | Renewal fee | 11.07.1995 | Renewal fee patent year 03 | 11.07.1996 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0172744 (NEW ZEALAND DEV FINANCE [NZ]); | [A]EP0206802 (NEW ZEALAND DEV FINANCE [NZ]); | [XP]EP0494623 (GLAXO LAB SA [FR]) | [A] - JOURNAL OF MEDICINAL CHEMISTRY vol. 31, no. 3, March 1988, WASHINGTON US pages 707 - 712 BRIAN D. PALMER ET AL 'Potential antitumor agents.54.Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides' |